國立陽明大學醫學系醫學士 
　國立陽明大學臨床醫學研究所博士

　多倫多綜合醫院進修

　臺北榮民總醫院 健康管理中心科主任                                          臺北榮民總醫院外科部住院醫師及總醫師
　臺北榮民總醫院胸腔外科總醫師
　臺北榮民總醫院胸腔外科研究醫師
　竹東榮民醫院外科主治醫師
　臺北榮民總醫院胸腔外科主治醫師
　國立陽明交通大學醫學院外科學系部定 教授

   外科專科醫師
　胸腔及心臟血管外科專科醫師
　胸腔外科專科醫師
　胸腔暨重症加護專科醫師
　重症醫學專科醫師
　外科重症專科醫師 

1. Hsu PK, Yeh YC, Chien LI, Huang CS, Hsu HS. Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020 [Epub ahead of print] (SCI)
2. Tsai PC, Hsu PK, Yeh YC, Chen CK, Chang YY, Huang CS, Hsu HS. Active surveillance or early resection for ground-glass nodules that need preoperative localization. J Surg Oncol. 2021;123:322-331. (correspondence; SCI)
3. Yeh JCY, Yu WH, Yang CK, Chien LI, Lin KH, Huang WS, Hsu PK. Predicting aggressive histopathological features in esophageal cancer with positron emission tomography using a deep convolutional neural network. Ann Transl Med. 2020 [Accepted] (correspondence; SCI)
4. Ke HH, Hsu PK, Tsou MY, Ting CK. Nonintubated video-assisted thoracic surgery with high-flow oxygen therapy shorten hospital stay. J Chin Med Assoc. 2020;83:943-9. (SCI)
5. Huang CS, Chien HC, Chen CK, Yeh YC, Hsu PK, Chen HS, Hsieh CC, Hsu HS, Huang BS, Shih CC. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2020 [Epub ahead of print] (SCI)
6. Hsu PK, Chuang LC, Wu YC. Electromagnetic navigation-guided preoperative localization for small malignant pulmonary tumors. Ann Thorac Surg. 2020;109:1566-1573 (SCI)
7. Hsu PK, Chuang LC, Ting CK, Tsou MY. Non-intubated electromagnetic-guided localization and resection of small indeterminate peripheral pulmonary nodules. Respirology. 2020 25:1095-6. (SCI)
8. Liu CY, Hsu PK, Leong KI, Ting CK, Tsou MY. Is tubeless uniportal video-assisted thoracic surgery for pulmonary wedge resection a safe procedure? Eur J Cardiothorac Surg. 2020;58:i70-6. (correspondence; SCI)
9. Lin CM, Tu CC, Yeh YC, Hsu PK, Chien LI, Huang CS, Wu YC, Hsu HS. The prognostic impact of extracapsular lymph node involvement in esophageal squamous cell carcinoma. Ann Surg Oncol. 2020;27:3071-82. (correspondence; SCI)
10. Hung CT, Chen CK, Chang YY, Hsu PK, Hung JJ, Huang CS, Wu YC, Hsu HS. Electromagnetic navigation-guided versus computed tomography-guided percutaneous localization of small lung nodules before uniportal video-assisted thoracoscopic surgery: A propensity score-matched analysis. Eur J Cardiothorac Surg. 2020;58:i85-90. (correspondence; SCI)
11. Hsu CP, Chuang CY, Hsu PK, Chien LI, Lin CH, Yeh YC, Hsu HS, Wu YC. Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy. J Gastrointest Surg. 2020;24:1459-68. (co-first author) (SCI)
12. Liu CY, Hsu PK, Hsu HS, Wu YC, Chuang CY, Lin CH, Hsu CP. Prognostic impact of circumferential resection margin in esophageal cancer with or without neoadjuvant chemoradiotherapy. Dis Esophagus. 2020;33:doz114. (co-first author) (SCI)
13. Huang CS, Hsu PK, Chen CK, Yeh YC, Hsu HS, Shih CC, Huang BS. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm. Thorac Cancer. 2020;11:907-917. (SCI)
14. Huang CS, Hsu PK, Chen CK, Yeh YC, Chen HS, Wu MH, Chou TY, Hsu WH, Shih CC, Huang BS. Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lung. Surg Today. 2020;50:673-84. (SCI)
15. Huang CS, Hsu PK, Chen CK, Yeh YC, Shih CC, Huang BS. Delayed surgery after histologic or radiologic-diagnosed clinical stage I lung adenocarcinoma. J Thorac Dis. 2020;12:615-625. (SCI)
16. Tsai PC, Yeh YC, Hsu PK, Chen CK, Chou TY, Wu YC. CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma. Ann Surg Oncol. 2020;27:4405-12. (SCI)
17. Lin YH, Chen CK, Hsieh CC, Hsu WH, Wu YC, Hung JJ, Hsu PK, Hsu HS. Lymphadenectomy is Unnecessary for Pure Ground-Glass Opacity Pulmonary Nodules. J Clin Med. 2020;9:672. (SCI)
18. Lee YY, Hsu PK, Huang CS, Wu YC, Hsu HS. Complications after Chest Tube Removal and Reinterventions in Patients with Digital Drainage Systems. J Clin Med. 2019;8:2092. (correspondence; SCI)
19. Yang CK, Yeh JC, Yu WH, Chien LI, Lin KH, Huang WS, Hsu PK. Deep convolutional neural network-based positron emission tomography analysis predicts esophageal cancer outcome. J Clin Med. 2019 Jun 13;8(6). pii: E844. (correspondence; SCI)
20. Hsu PK, Wu YC. The feasibility of electromagnetic navigation-guided percutaneous microcoil localization for thoracoscopic resection of small pulmonary nodules. J Thorac Cardiovasc Surg. 2019 157:e211-4. (SCI)
21. Hsu PK, Chien LI, Lin CH, Yeh YC, Chuang CY, Hsu HS, Wu YC, Hsu CP. Impact of perineural invasion as a histopathological prognostic factor in ypStage II/III oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2019;55:927-33. (SCI)
22. Hsu PK, Chen HS, Liu CC, Wu SC. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2019:26:506-13. (SCI)
23. Hsu PK. Tissue graft to cover diaphragmatic defects in a patient with catamenial pneumothorax. Ann Thorac Surg. 2019;107:e143. (SCI)
24. Tu CC, Hsu PK. Current choices and prospects in management of postoperative esophageal cancer patients. Asian J Surg. 2019;42:81-4. (correspondence; SCI)
25. Hsu PK, Wu YC. Electromagnetic navigation-guided one-stage dual localization of small pulmonary nodules. Chest. 2018;154:1462-3. (SCI)
26. Tsai PC, Yeh YC, Hsu PK, Wu YC. "No drain" uniportal thoracoscopic resection for posterior mediastinal paravertebral Mullerian cyst. Ann Transl Med. 2018;6:462. (Correspondence)
27. Ho HJ, Chen HS, Hung WH, Hsu PK, Wu SC, Chen HC, Wang BY. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation. Ann Surg Oncol. 2018;25:3820-32. (SCI)
28. Liu CY, Hsu PK, Chien HC, Hsieh CC, Ting CK, Tsou MY. Tubeless single-port thoracoscopic sublobar resection: indication and safety. J Thorac Dis. 2018;10:3729-37. (correspondence; SCI)
29. Tu CC, Hsu PK. The frontline of esophageal cancer treatment: questions to be asked and answered. Ann Transl Med. 2018;6:83. (correspondence)
30. Hsu PK. The era of personalized multimodal treatments for esophageal cancer. Ann Transl Med. 2018;6:75. (correspondence)
31. Tu CC, Hsu PK. Possible refinement of the standard treatment of esophageal cancer. J Thorac Dis. 2018;10:E90-2. (correspondence; SCI)
32. Hsu PK, Chen HS, Liu CC, Wu SC. Application of the 8th AJCC TNM Staging System in Patients with Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2018;105:1516-22. (SCI)
33. Chen HS, Hsu PK, Liu CC, Wu SC. Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma. Sci Rep. 2018;8:2180. (correspondence; SCI)
34. Hsu PK. Do we have enough evidence for adjuvant postoperative chemoradiation in esophageal cancer? J Thorac Dis. 2017;9:1777-1779. (SCI)
35. Hsu PK, Chen HS, Liu CC, Huang CS, Hsieh CC, Hsu HS, Wu SC. Pre- versus Postoperative Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. J Thorac Cardiovasc Surg 2017;154:732-40. (SCI)
36. Wu CH, Hsu PK, Yeh YC, Chen CK. Achieving a shorter pleura-to-lesion distance by using a coil to mark the fissure side in preoperative lung nodule localization. Kaohsiung J Med Sci. 2017;33:104-6. (SCI)
37. Hsu PK, Chien LI, Wang LC, Chou TY. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and esophagectomy in patients with esophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2017;51:1188-94. (SCI)
38. Tu CC, Hsu PK, Chien LI, Liu WC, Huang CS, Hsieh CC, Hsu HS, Wu YC. Prognostic Histological Factors in Patients with Esophageal Squamous Cell Carcinoma after Preoperative Chemoradiation Followed by Surgery. BMC Cancer 2017;17:62. (correspondence; SCI)
39. Hsu PK, Chen HS, Huang CS, Liu CC, Hsieh CC, Hsu HS, Wu YC, Wu SC. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma. Br J Surg 2017;104:90-7. (SCI)
40. Chao YK, Chen HS, Wang BY, Hsu PK, Liu CC, Wu SC. Factors associated with survival in patients with oesophageal cancer who achieve pathological complete response after chemoradiotherapy: a nationwide population-based study. Eur J Cardiothorac Surg. 2017;51:155-9. (SCI)
41. Tu CC, Hsu PK. The long-waited high level evidence in thoracic surgery. Ann Transl Med. 2016;4:383.
42. Tu CC, Hsu PK. Global development and current evidence of uniportal thoracoscopic surgery. J Thorac Dis. 2016;8(Suppl 3):S308-18. (correspondence; SCI))
43. Chen HS, Hung WH, Ko JL, Hsu PK, Liu CC, Wu SC, Lin CH, Wang BY. Impact of treatment modalities on survival of patients with locoregional esophageal squamous-cell carcinoma in Taiwan. Medicine (Baltimore). 2016;95:e3018. (SCI)
44. Chao YK, Chen HS, Wang BY, Hsu PK, Liu CC, Wu SC. Prognosis of patients with pathologic T0N+ esophageal squamous cell carcinoma after chemoradiotherapy and surgical resection: results from a nationwide study. Ann Thorac Surg. 2016;101:1897-902. (SCI)
45. Chein HC, Chen HS, Wu SC, Hsu PK, Liu CY, Wang BY, Shih CH, Liu CC. The prognostic value of metastatic lymph node number and ratio in esophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation. Eur J Cardiothorac Surg 2016;50:337-43. (correspondence; SCI)
46. Hwang JY, Chen HS, Hsu PK, Chao YK, Wang BY, Huang CS, Liu CC, Wu SC. A Propensity - Matched Analysis Comparing Survival after Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma. Ann Surg 2016;264:100-6. (correspondence; SCI)